| http://dbpedia.org/ontology/abstract
|
Dapagliflozin/saxagliptin, sold under the … Dapagliflozin/saxagliptin, sold under the brand name Qtern, is a fixed-dose combination anti-diabetic medication used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is a combination of dapagliflozin and saxagliptin. It is taken by mouth. The most common side effects include upper respiratory tract infection (such as nose and throat infections) and, when used with a sulphonylurea, hypoglycaemia (low blood glucose levels). Dapagliflozin/saxagliptin was approved for medical use in the European Union in July 2016, and in the United States in February 2017.and in the United States in February 2017.
|
| http://dbpedia.org/ontology/alternativeName
|
Qtern
|
| http://dbpedia.org/ontology/casNumber
|
2446322-16-1
|
| http://dbpedia.org/ontology/kegg
|
D10826
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://medlineplus.gov/druginfo/meds/a610003.html +
, https://druginfo.nlm.nih.gov/drugportal/rn/361442-04-8 +
, https://medlineplus.gov/druginfo/meds/a614015.html +
, https://druginfo.nlm.nih.gov/drugportal/name/dapagliflozin%20propanediol +
|
| http://dbpedia.org/ontology/wikiPageID
|
63133081
|
| http://dbpedia.org/ontology/wikiPageLength
|
6847
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1009878289
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Dapagliflozin +
, http://dbpedia.org/resource/Category:Tertiary_alcohols +
, http://dbpedia.org/resource/Category:Adamantanes +
, http://dbpedia.org/resource/Category:Nitriles +
, http://dbpedia.org/resource/Saxagliptin +
, http://dbpedia.org/resource/Category:Chloroarenes +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Category:Anti-diabetic_drugs +
, http://dbpedia.org/resource/Type_2_diabetes +
, http://dbpedia.org/resource/Category:Nitrogen_heterocycles +
, http://dbpedia.org/resource/SGLT-2_inhibitor +
, http://dbpedia.org/resource/Category:AstraZeneca_brands +
, http://dbpedia.org/resource/Category:Phenol_ethers +
, http://dbpedia.org/resource/Dipeptidyl_peptidase-4_inhibitor +
, http://dbpedia.org/resource/Category:Combination_drugs +
, http://dbpedia.org/resource/Category:Dipeptidyl_peptidase-4_inhibitors +
, http://dbpedia.org/resource/Oral_administration +
, http://dbpedia.org/resource/Combination_drug +
, http://dbpedia.org/resource/Diabetes_management +
, http://dbpedia.org/resource/Category:SGLT2_inhibitors +
, http://dbpedia.org/resource/Anti-diabetic_medication +
, http://dbpedia.org/resource/Category:Glucosides +
|
| http://dbpedia.org/property/atcPrefix
|
A10
|
| http://dbpedia.org/property/atcSuffix
|
BD21
|
| http://dbpedia.org/property/casNumber
|
2446322
|
| http://dbpedia.org/property/class
|
http://dbpedia.org/resource/Dipeptidyl_peptidase-4_inhibitor +
, http://dbpedia.org/resource/SGLT-2_inhibitor +
|
| http://dbpedia.org/property/component
|
Dapagliflozin
, Saxagliptin
|
| http://dbpedia.org/property/dailymedid
|
Qtern
|
| http://dbpedia.org/property/kegg
|
D10826
|
| http://dbpedia.org/property/legalEu
|
Rx-only
|
| http://dbpedia.org/property/legalUs
|
Rx-only
|
| http://dbpedia.org/property/pregnancyAu
|
D
|
| http://dbpedia.org/property/pregnancyUs
|
N
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Oral_administration +
|
| http://dbpedia.org/property/tradename
|
Qtern
|
| http://dbpedia.org/property/type
|
combo
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Portal_bar +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Oral_hypoglycemics_and_insulin_analogs +
, http://dbpedia.org/resource/Template:Gastrointestinal-drug-stub +
, http://dbpedia.org/resource/Template:Primary_sources +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:Drugs.com +
, http://dbpedia.org/resource/Template:Sodium-glucose_transporter_modulators +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:AstraZeneca_brands +
, http://dbpedia.org/resource/Category:Anti-diabetic_drugs +
, http://dbpedia.org/resource/Category:Nitrogen_heterocycles +
, http://dbpedia.org/resource/Category:Nitriles +
, http://dbpedia.org/resource/Category:Tertiary_alcohols +
, http://dbpedia.org/resource/Category:Adamantanes +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Category:Chloroarenes +
, http://dbpedia.org/resource/Category:Phenol_ethers +
, http://dbpedia.org/resource/Category:Dipeptidyl_peptidase-4_inhibitors +
, http://dbpedia.org/resource/Category:Glucosides +
, http://dbpedia.org/resource/Category:Combination_drugs +
, http://dbpedia.org/resource/Category:SGLT2_inhibitors +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Dapagliflozin/saxagliptin?oldid=1009878289&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Dapagliflozin/saxagliptin +
|
| owl:sameAs |
http://dbpedia.org/resource/Dapagliflozin/saxagliptin +
, https://global.dbpedia.org/id/FLcqb +
, http://www.wikidata.org/entity/Q104843718 +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/CombinationDrug +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Dapagliflozin/saxagliptin, sold under the … Dapagliflozin/saxagliptin, sold under the brand name Qtern, is a fixed-dose combination anti-diabetic medication used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is a combination of dapagliflozin and saxagliptin. It is taken by mouth. The most common side effects include upper respiratory tract infection (such as nose and throat infections) and, when used with a sulphonylurea, hypoglycaemia (low blood glucose levels). hypoglycaemia (low blood glucose levels).
|
| rdfs:label |
Dapagliflozin/saxagliptin
|
